Masaya Takemoto
Kanazawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Binding capacity of Intravenous immunoglobulin G to BK polyomavirus determines its anti-BK polyomavirus activity in infected cultures.
Journal: European journal of pharmacology
Published: March 09, 2026
Mechanistic insights into the inhibition of drug-resistant cytomegalovirus by letermovir and ganciclovir.
Journal: British journal of pharmacology
Published: January 29, 2025
Vertical mother-to-infant transmission of herpes simplex virus 2 is correlated with tropism due to mutations in viral UL13.
Journal: Journal of medical virology
Published: October 30, 2023
Butein inhibits corticosterone-induced apoptosis of Neuro2A cells by maintaining MEK-ERK signaling.
Journal: IBRO neuroscience reports
Published: March 21, 2023
The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus.
Journal: Microbiology spectrum
Published: February 09, 2022
Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences.
Journal: Pharmacology & therapeutics
Published: January 20, 2022
Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment.
Journal: Expert review of anti-infective therapy
Published: April 15, 2021
Erratum to 'Inhibition of human cytomegalovirus replication by tricin is associated with depressed CCL2 expression' [Antiviral Research (2017) 15-19].
Journal: Antiviral research
Published: March 10, 2018
An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
Journal: Antiviral research
Published: January 28, 2018
The anti-human cytomegalovirus drug tricin inhibits cyclin-dependent kinase 9.
Journal: FEBS open bio
Published: November 29, 2017
Last Updated: 09/26/2026